Moses Lake Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
Moses Lake Professional Pharmacy is recalling Estradiol 25 mg pellets because the agency cannot assure the sterility of the compounded drug.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential health risks.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling Estradiol 25 mg pellets. The recall was initiated due to a lack of assurance of sterility for the sterile human compounded drugs.
The affected product consists of 10 pellets per package. The recall covers lots with the following codes: t10222014@3, t10202014@24, t09022014@12, t08082014@20, t07222014@33, t06112015@38, t04232015@28, t04072015@12, t02182015@7, and t01122015@14. The product was distributed nationwide.
Patients who have received these pellets should contact their healthcare provider or the pharmacy for further instructions on how to proceed with their medication.
The recalled product
- Product
- ESTRADIOL, Pellet, 25 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 10
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- t10222014@3
- t10202014@24
- t09022014@12
- t08082014@20
- t07222014@33
- t06112015@38
- t04232015@28
- t04072015@12
- t02182015@7
- t01122015@14.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SevereEstradiol Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereEstradiol Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- CriticalPhysician Preferred Medical Recalls Epel 18 mg Estradiol Pellets Due to Sterility Failure
FDA (Drugs) · 2015-05-13
- SevereQualgen Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2018-11-14
- SevereFDA Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-09-23